Encision Reports Third Quarter Fiscal Year 2022 Results
BOULDER, CO / ACCESSWIRE / February 10, 2022 / Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active...
Month: February 2022
Enhancement Center Expands to New Location in Grants, NM
Therapist now offering mental health services to people coming out of the Cibola County court system and the general publicALBUQUERQUE,...
Systemic Therapeutics Uncovers the Protective Mechanism of Caffeine Against Cardiovascular Disease
Hamilton, Ontario--(Newsfile Corp. - February 9, 2022) - Scientists from Systemic Therapeutics Corp. (the "Company" or "SystemicTx") have a new...
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2022 Financial Results on February 15, 2022
Financials for Third Quarter Fiscal Year 2022 Ended December 31, 2021 will be released February 14, 2022NORTHVALE, NJ / ACCESSWIRE...
TRxADE HEALTH to Present at Aegis Virtual Conference
TAMPA, FL / ACCESSWIRE / February 9, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS)("TRxADE" or the "Company"), a health services IT...
Moderna Chief Technical Operations and Quality Officer Juan Andres Elected to National Academy of Engineering
CAMBRIDGE, MA / ACCESSWIRE / February 9, 2022 / Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics...
MVIS Launches the MVIS Global Bionic Healthcare ESG Index
Index providing exposure to the bionic healthcare sector FRANKFURT, Germany--(BUSINESS WIRE)--MV Index Solutions GmbH (MVIS®) today announced the launch of...
CVR Medical Corp. Announces Upcoming Annual General Meeting
Vancouver, British Columbia--(Newsfile Corp. - February 9, 2022) - CVR Medical Corp. (TSXV: CVM) (OTCQB: CRRVF) ("CVR Medical" or the...
IMPLANET Announces the First Surgical Procedures in the United States with JAZZ™ PF
JAZZ™ PF: a simple, innovative and proprietary addition to the JAZZ® range Addressable annual market of almost $350 million in...
Visiting Angels Scores High Marks in New Franchise Business Review Survey
Senior Home Care Provider Receives #1 Ranking in Competitive CategoryBRYN MAWR, PA / ACCESSWIRE / February 9, 2022 / Visiting...
Medovate Announces Exclusive US Distribution Agreement with Mercury Medical(R) for SAFIRA(R)
CLEARWATER, FL / ACCESSWIRE / February 9, 2022 / Medovate, a UK based medical device development company, has announced that...
Go Figure Coaching Founder, Vicky Midwood, Reveals Her Secret Method To Help People Achieve Food & Alcohol Freedom
LONDON, ENGLAND / ACCESSWIRE / February 9, 2022 / Go Figure Coaching, a coaching business that helps high-achievers address food...
Altamira Therapeutics and Wellesta Expand Bentrio Marketing and Distribution Agreement to Include Two Additional Markets
HAMILTON, BERMUDA / ACCESSWIRE / February 9, 2022 / Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to developing therapeutics that...
Emergent Health Appoints Former Vice-President and Director of Enzolytics, James Zimbler as Chief Executive Officer
KING OF PRUSSIA, PA / ACCESSWIRE / February 9, 2022 / Emergent Health Corp., (OTC PINK:EMGE) announces the appointment of...
Novus Cannabis MedPlans is Well-Received at Major ICMG Insurance Conference
Market Changes Gather Interest From Carriers and Wholesalers, Prompting Distribution Agreements To A Larger Target AudienceMIAMI, FL / ACCESSWIRE /...
AiCuris and Hybridize Therapeutics Enter Worldwide License Agreement of up to €100M for a Direct-Acting RNA-Based Therapy Against BK Virus
AiCuris acquires exclusive rights to develop and commercialize Hybridize's program to prevent severe disease from BK virus (BKV) infections in...
Aptevo Therapeutics Earns $10 Million Non-Dilutive Milestone Payment on Sales of RUXIENCE, Provides Company Update
APVO436 Phase 1b Trial for Acute Myeloid Leukemia Adds New SiteComplete Remission Patient to Advance to TransplantSEATTLE, WA / ACCESSWIRE...
9 Meters Biopharma to Present at the 2022 BIO CEO & Investor Conference
RALEIGH, NC / ACCESSWIRE / February 9, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments...
INVO Bioscience Eyes +20 U.S. Cities To Expand Rollout Of Advanced Infertility Treatment ‘INVO Centers’
SAN FRANCISCO, CA / ACCESSWIRE / February 9, 2022 / Today, the global fertility market is a multi-billion industry, yet...
Sonnet BioTherapeutics Announces Abstract Accepted for Presentation in a Poster Session at the AACR 2022 Annual Meeting
PRINCETON, NJ / ACCESSWIRE / February 9, 2022 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical...